Select Guide Rating

• The Old but New IgM Fc Receptor (FcμR).- Emerging Roles for FCRL Family Members in Lymphocyte Biology and Disease.- Intracellular antibody immunity and the cytosolic Fc receptor TRIM21.- Computational modeling of the main signaling pathways involved in mast cell activation.- Calcium channels in FcR signaling.- Regulation of FcεRI signaling by lipid phosphatases.- Fc Receptors as Adaptive Immunoreceptors.- Glycosylation and Fc Receptors.- Antibodies as natural adjuvants.- IgA, IgA receptors and their anti-inflammatory properties.- Humanized mice to study FcγR function.- FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions.- Human FcR polymorphism and disease.- Bridging auto-antibodies and arthritis; the role of Fc Receptors.- The FcγR of humans and non-human primates and their interaction with IgG: Implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies.- FcgRIIB as a key determinant of agonistic antibody efficacy.- Fc receptor dependent mechanisms of monoclonal antibody therapy of cancer; professionals at work.- Sweet and Sour: The role of glycosylation for the anti-inflammatory activity of immunoglobulin G.

Select Guide Rating

• The Old but New IgM Fc Receptor (FcμR).- Emerging Roles for FCRL Family Members in Lymphocyte Biology and Disease.- Intracellular antibody immunity and the cytosolic Fc receptor TRIM21.- Computational modeling of the main signaling pathways involved in mast cell activation.- Calcium channels in FcR signaling.- Regulation of FcεRI signaling by lipid phosphatases.- Fc Receptors as Adaptive Immunoreceptors.- Glycosylation and Fc Receptors.- Antibodies as natural adjuvants.- IgA, IgA receptors and their anti-inflammatory properties.- Humanized mice to study FcγR function.- FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions.- Human FcR polymorphism and disease.- Bridging auto-antibodies and arthritis; the role of Fc Receptors.- The FcγR of humans and non-human primates and their interaction with IgG: Implications for induction of inflammation, resistance to infection and the use of therapeutic monoclonal antibodies.- FcgRIIB as a key determinant of agonistic antibody efficacy.- Fc receptor dependent mechanisms of monoclonal antibody therapy of cancer; professionals at work.- Sweet and Sour: The role of glycosylation for the anti-inflammatory activity of immunoglobulin G.